Takeda Receives FDA Approval for Oseni (alogliptin and pioglitazone) for Type 2 Diabetes

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc.

[dailyRx]

It's great to see such progress in diabetes treatment. However, it is important for patients to be aware of the difficulties that can be accompanied by the medications. Side effects go from being as simple as allergies to as severe as liver damage. You can read in depth descriptions for each of the new drugs at www.RxWiki.com .